Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XALKORI ROS1+NSCLC DRUG USE INVESTIGATION

NCT03375242 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03375242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03375242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XALKORI ROS1+NSCLC DRUG USE INVESTIGATION
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 25, 2017
Completion date
August 10, 2026
Enrollment
97 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer